We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
Cap. Flow
+$245M
Cap. Flow %
17.64%
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908

Sector Composition

Rank Sector Weight
1 Healthcare 6.26%
2 Financials 5.86%
3 Technology 5.03%
4 Energy 4.85%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASFI
3726
DELISTED
Asta Funding Inc
ASFI
$1K ﹤0.01%
172
+99
+136% +$391
BCOM
3727
DELISTED
B Communications Ltd
BCOM
$1K ﹤0.01%
+100
New +$849
BCTF
3728
DELISTED
Bancorp 34, Inc. Common Stock
BCTF
$1K ﹤0.01%
44
-91
-67% -$1.39K
CYRXW
3729
DELISTED
CryoPort, Inc. Warrants
CYRXW
$1K ﹤0.01%
95
MSBF
3730
DELISTED
MSB Financial Corp.
MSBF
$1K ﹤0.01%
55
GPAQU
3731
DELISTED
Gordon Pointe Acquisition Corp. Unit
GPAQU
$1K ﹤0.01%
100
-200
-67% -$2.08K
TIVO
3732
DELISTED
Tivo Inc
TIVO
$1K ﹤0.01%
61
-2,395
-98% -$25.8K
JCP
3733
DELISTED
J.C. Penney Company, Inc.
JCP
$1K ﹤0.01%
700
-124,856
-99% -$175K
RBZ
3734
DELISTED
Reebonz Holding Limited Ordinary Shares
RBZ
$1K ﹤0.01%
+35
New +$729
AVX
3735
DELISTED
AVX Corporation
AVX
$1K ﹤0.01%
93
-507
-85% -$8.18K
FOMX
3736
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$1K ﹤0.01%
357
-486
-58% -$2.11K
DERM
3737
DELISTED
Dermira, Inc.
DERM
$1K ﹤0.01%
+208
New +$2.28K
CFRX
3738
DELISTED
ContraFect Corporation
CFRX
$1K ﹤0.01%
+1
New +$1.59K
ABDC
3739
DELISTED
Alcentra Capital Corp
ABDC
$1K ﹤0.01%
+191
New +$1.19K
JASN
3740
DELISTED
Jason Industries, Inc.
JASN
$1K ﹤0.01%
+500
New +$1.14K
CART
3741
DELISTED
Carolina Trust BancShares
CART
$1K ﹤0.01%
+147
New +$1.18K
SMTA
3742
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
$1K ﹤0.01%
81
ANFI
3743
DELISTED
AMIRA NATURE FOODS LTD
ANFI
$1K ﹤0.01%
2,908
-11,946
-80% -$9.1K
LTXB
3744
DELISTED
LegacyTexas Financial Group Inc
LTXB
$1K ﹤0.01%
41
-1,388
-97% -$53K
MMDM
3745
DELISTED
Modern Media Acquisition Corp. Common Stock
MMDM
$1K ﹤0.01%
+65
New +$659
ADOM
3746
DELISTED
ADOMANI Inc
ADOM
$1K ﹤0.01%
4,366
+98
+2% +$44
USG
3747
DELISTED
Usg
USG
$1K ﹤0.01%
+34
New +$1.46K
DDE
3748
DELISTED
Dover Downs Gaming & Entertain
DDE
$1K ﹤0.01%
498
-10,152
-95% -$25K
CLD
3749
DELISTED
Cloud Peak Energy Inc
CLD
$1K ﹤0.01%
+3,254
New +$4.63K
ANCX
3750
DELISTED
Access National Corp
ANCX
$1K ﹤0.01%
26
+25
+2,500% +$631

Similar funds

Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review

As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
  • Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
  • Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.